Medical News

Incidence and Risk Factors of Community-Acquired Pneumonia in Hematologic Oncologic Patients

5. 7. 2022 Source: Anti-Infectives

Patients with hematologic malignancies are at higher risk of infectious diseases, particularly community-acquired pneumonia, due to immunosuppression. However, recent data providing information on the incidence and risk factors of community-acquired pneumonia in this patient group are quite limited. The aim of the cohort study published by Dutch authors was therefore to supplement the missing recent information on the issue of community-acquired pneumonia in hematologic oncologic patients.

Summary of New American Recommendations for Heart Failure Management

This year, the American Heart Association (AHA), the American College of Cardiology (ACC), and the Heart Failure Society of America (HFSA) released joint recommendations for the diagnosis and…

28. 6. 2022 Source: Heart Failure

Full Compensation of Seizures as the Main Goal of Epilepsy Therapy: Will Patients Achieve It More Easily Than 20 Years Ago?

What is the relationship between the quality of life of patients and the degree of seizure compensation? Have the new antiepileptics (ASM) developed over the last decades improved the overall success…

28. 6. 2022 Source: Epilepsy

Safety Profile of Metamizole –⁠ A Systematic Review

Metamizole is a long-established non-steroidal analgesic used for acute and chronic pain management. A systematic review of the literature published in the Journal of Clinical Pharmacy and…

28. 6. 2022 Source: Analgesia

Early and effective treatment of PBC significantly reduced the need for liver transplantation due to this disease

Current European and Czech guidelines include obeticholic acid (OCA) as the only registered option for 2nd line treatment of primary biliary cholangitis (PBC). In the Czech Republic, it is approved…

23. 6. 2022 Source: Primary Biliary Cholangitis

Iron Deficiency and Administration of Ferric Carboxymaltose in Patients with Heart Failure

Iron deficiency is very common in patients with heart failure and is associated with exercise intolerance, reduced quality of life, increased mortality, and higher risk of hospitalization, regardless…

21. 6. 2022 Source: Iron Deficiency and Anemia

Does empagliflozin improve the overall health of patients with heart failure with reduced LVEF?

A recently published secondary analysis of the EMPEROR-Reduced study is based mainly on the results of the KCCQ-23 questionnaire, which assesses the patient's health status from their perspective.…

21. 6. 2022 Source: Heart Failure

Comparison of Dabigatran and Vitamin K Antagonists in Patients with Atrial Fibrillation in Real-World Practice

The final 3-year results of the GLORIA-AF study conducted in real-world practice with patients newly diagnosed with atrial fibrillation show a lower incidence of major bleeding and lower overall…

21. 6. 2022 Source: Anticoagulant Treatment

Low-Molecular-Weight Heparins in Thromboprophylaxis After Major Orthopedic and Traumatological Procedures According to Current Recommendations

Patients after major orthopedic and traumatological procedures are at high risk of thromboembolic disease. This is especially true for people undergoing hip and knee replacement or patients with a proximal...

20. 6. 2022 Source: Thromboprophylaxis

Dupilumab Improves Skin and Systemic Symptoms of Atopic Dermatitis

A clinical study conducted in the USA and Canada demonstrated the efficacy of dupilumab in treating moderate to severe atopic dermatitis, improving both skin symptoms and suppressing systemic…

20. 6. 2022 Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation

Current View on Prophylactic Negative Pressure Wound Therapy in Practice from Surgeons' Perspective

The journal Updates in Surgery recently published the results of a survey on prophylactic negative-pressure wound therapy (pNPWT) conducted among Swiss surgeons. The survey results show how often…

17. 6. 2022 Source: Wound Healing

Comparison of the effects of fibrinogen concentrates and fresh frozen plasma in patients with acute traumatic coagulopathy

A quasi-experimental study compared the effectiveness of fibrinogen concentrates and fresh frozen plasma in patients with severe blunt trauma requiring the administration of erythrocyte replacements.

15. 6. 2022 Source: Life-threatening Bleeding

Fibrinogen and Management of Peripartum Life-Threatening Hemorrhage

The most common cause of maternal death in the developed world continues to be peripartum life-threatening hemorrhage. It can result as a consequence of the consumption of coagulation factors,…

15. 6. 2022 Source: Life-threatening Bleeding

Telmisartan, amlodipine, and chlorthalidone in a low-dose fixed triple combination –⁠ better control of target blood pressure values?

The secondary analysis of the TRIUMPH study, recently published in JAMA Cardiology, is likely the first published assessment of time spent in the target blood pressure (BP) range during…

15. 6. 2022 Source: Sartans in the Treatment of Hypertension

Joystick-operated robot intervening in stroke treatment remotely −⁠ fiction or promise of the future?

A team of experts from the Massachusetts Institute of Technology (MIT) has developed a telerobotic system that could allow doctors to treat stroke or brain aneurysm remotely in the future. Scientists…

15. 6. 2022 Source: proLékaře.cz

1 … 47 48 49 50 51 … 111

Back Filter by speciality

Remove filters

Popular this week